SAM
Sectoral Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Hold |
2,540
| – | – | 0.08% | 92 |
|
|
2025
Q1 | $86.4K | Buy |
+2,540
| New | +$86.4K | 0.07% | 82 |
|
|
2023
Q1 | – | Sell |
-2,490
| Closed | -$101K | – | 121 |
|
|
2022
Q4 | $101K | Hold |
2,490
| – | – | 0.02% | 120 |
|
|
2022
Q3 | $163K | Hold |
2,490
| – | – | 0.03% | 106 |
|
|
2022
Q2 | $151K | Sell |
2,490
-780
| -24% | -$47.3K | 0.03% | 108 |
|
|
2022
Q1 | $205K | Hold |
3,270
| – | – | 0.04% | 106 |
|
|
2021
Q4 | $248K | Hold |
3,270
| – | – | 0.04% | 105 |
|
|
2021
Q3 | $366K | Hold |
3,270
| – | – | 0.03% | 122 |
|
|
2021
Q2 | $529K | Hold |
3,270
| – | – | 0.04% | 114 |
|
|
2021
Q1 | $398K | Sell |
3,270
-21,700
| -87% | -$2.64M | 0.03% | 106 |
|
|
2020
Q4 | $3.82M | Buy |
+24,970
| New | +$3.82M | 0.27% | 73 |
|
|
2020
Q3 | – | Sell |
-114,400
| Closed | -$8.41M | – | 112 |
|
|
2020
Q2 | $8.41M | Buy |
114,400
+103,650
| +964% | +$7.62M | 0.77% | 51 |
|
|
2020
Q1 | $456K | Buy |
+10,750
| New | +$456K | 0.09% | 64 |
|